http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SE-7607630-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_067f025130cf4d36c59692a991e190a4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
filingDate 1976-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecb3cc8308443c1d8707be7391af3645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b035fa1cc19e1c087603608af6a2122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b189687ea66d4f65a08c09a71dbc615e
publicationDate 1977-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SE-7607630-L
titleOfInvention ASSOCIATION FOR THE TREATMENT OF BOVIN MASTIT
abstract Compositions for the treatment of bovine mastitis are provided. Said compositions comprise as active compound [2-carboxy-4-/2'-(5'-nitrofuryl)]quinoline N-oxide. The method is performed in such a manner that the composition is administered to the animal, preferably by way of intramamary infusion.
priorityDate 1975-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414877223
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15366

Total number of triples: 20.